The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of bevacizumab in patients with surgery and radiation refractory progressive meningioma.
 
Sean Aaron Grimm
Employment - Lundbeck (I)
Consulting or Advisory Role - Abbvie; Novocure
 
Priya Kumthekar
Consulting or Advisory Role - Angiochem; Novocure
 
Marc C. Chamberlain
No Relationships to Disclose
 
David Schiff
Consulting or Advisory Role - Genentech/Roche
 
Patrick Y. Wen
Consulting or Advisory Role - Abbvie; Cavion; Celldex; Cubist; Genentech/Roche; Midatech Pharma; Momenta Pharmaceuticals; Novartis; Novocure; Sigma-Tau; Vascular Biogenics
Speakers' Bureau - Merck
Research Funding - Agios; Angiochem; AstraZeneca; Exelixis; Genentech/Roche; Karyopharm Therapeutics; Novartis; Sanofi; Vascular Biogenics
 
Fabio Massaiti Iwamoto
Consulting or Advisory Role - Novocure
Research Funding - Celldex; Northwest Biotherapeutics; Novocure; Plexxikon
 
David A. Reardon
Honoraria - Genentech/Roche
Consulting or Advisory Role - Genentech/Roche
Speakers' Bureau - Genentech/Roche
 
Benjamin Purow
No Relationships to Disclose
 
Jeffrey J. Raizer
Honoraria - EMD Serono; Genentech/Roche; Midatech Pharma; Novocure; Stemline Therapeutics
Consulting or Advisory Role - EMD Serono; Genentech/Roche; Midatech Pharma; Novocure; Stemline Therapeutics
Speakers' Bureau - Genentech/Roche
Research Funding - Genentech/Roche; Novartis; Plexxikon; Stemline Therapeutics